792 related articles for article (PubMed ID: 10823843)
1. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
Accola MA; Strack B; Göttlinger HG
J Virol; 2000 Jun; 74(12):5395-402. PubMed ID: 10823843
[TBL] [Abstract][Full Text] [Related]
2. Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag).
Sandefur S; Smith RM; Varthakavi V; Spearman P
J Virol; 2000 Aug; 74(16):7238-49. PubMed ID: 10906178
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of Vpr into human immunodeficiency virus type 1 requires a direct interaction with the p6 domain of the p55 gag precursor.
Bachand F; Yao XJ; Hrimech M; Rougeau N; Cohen EA
J Biol Chem; 1999 Mar; 274(13):9083-91. PubMed ID: 10085158
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
Wu X; Liu H; Xiao H; Kappes JC
Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547
[TBL] [Abstract][Full Text] [Related]
5. Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation.
Joshi A; Nagashima K; Freed EO
J Virol; 2006 Aug; 80(16):7939-51. PubMed ID: 16873251
[TBL] [Abstract][Full Text] [Related]
6. Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.
Wu X; Liu H; Xiao H; Conway JA; Hunter E; Kappes JC
EMBO J; 1997 Aug; 16(16):5113-22. PubMed ID: 9305652
[TBL] [Abstract][Full Text] [Related]
7. Biochemical analyses of the interactions between human immunodeficiency virus type 1 Vpr and p6(Gag).
Jenkins Y; Pornillos O; Rich RL; Myszka DG; Sundquist WI; Malim MH
J Virol; 2001 Nov; 75(21):10537-42. PubMed ID: 11581428
[TBL] [Abstract][Full Text] [Related]
8. Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses.
Selig L; Pages JC; Tanchou V; Prévéral S; Berlioz-Torrent C; Liu LX; Erdtmann L; Darlix J; Benarous R; Benichou S
J Virol; 1999 Jan; 73(1):592-600. PubMed ID: 9847364
[TBL] [Abstract][Full Text] [Related]
9. A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly.
Accola MA; Höglund S; Göttlinger HG
J Virol; 1998 Mar; 72(3):2072-8. PubMed ID: 9499062
[TBL] [Abstract][Full Text] [Related]
10. A conserved dileucine-containing motif in p6(gag) governs the particle association of Vpx and Vpr of simian immunodeficiency viruses SIV(mac) and SIV(agm).
Accola MA; Bukovsky AA; Jones MS; Göttlinger HG
J Virol; 1999 Dec; 73(12):9992-9. PubMed ID: 10559313
[TBL] [Abstract][Full Text] [Related]
11. Coding sequences upstream of the human immunodeficiency virus type 1 reverse transcriptase domain in Gag-Pol are not essential for incorporation of the Pr160(gag-pol) into virus particles.
Chiu HC; Yao SY; Wang CT
J Virol; 2002 Apr; 76(7):3221-31. PubMed ID: 11884546
[TBL] [Abstract][Full Text] [Related]
12. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.
Kondo E; Mammano F; Cohen EA; Göttlinger HG
J Virol; 1995 May; 69(5):2759-64. PubMed ID: 7707498
[TBL] [Abstract][Full Text] [Related]
13. Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.
Misumi S; Morikawa Y; Tomonaga M; Ohkuma K; Takamune N; Shoji S
J Biochem; 2004 Mar; 135(3):447-53. PubMed ID: 15113844
[TBL] [Abstract][Full Text] [Related]
14. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.
Huang M; Orenstein JM; Martin MA; Freed EO
J Virol; 1995 Nov; 69(11):6810-8. PubMed ID: 7474093
[TBL] [Abstract][Full Text] [Related]
15. Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.
Ono A; Demirov D; Freed EO
J Virol; 2000 Jun; 74(11):5142-50. PubMed ID: 10799589
[TBL] [Abstract][Full Text] [Related]
16. A novel fluorescence resonance energy transfer assay demonstrates that the human immunodeficiency virus type 1 Pr55Gag I domain mediates Gag-Gag interactions.
Derdowski A; Ding L; Spearman P
J Virol; 2004 Feb; 78(3):1230-42. PubMed ID: 14722278
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.
Liu H; Wu X; Xiao H; Conway JA; Kappes JC
J Virol; 1997 Oct; 71(10):7704-10. PubMed ID: 9311854
[TBL] [Abstract][Full Text] [Related]
18. C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain.
Yu FH; Huang KJ; Wang CT
J Virol; 2017 May; 91(10):. PubMed ID: 28250114
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity.
Yu FH; Wang CT
Retrovirology; 2018 Apr; 15(1):32. PubMed ID: 29655366
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.
Checroune F; Yao XJ; Göttlinger HG; Bergeron D; Cohen EA
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):1-7. PubMed ID: 7648278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]